about
Advances in antibiotic therapy in the critically illPerspective on optimizing clinical trials in critical care: how to puzzle out recurrent failuresAssessment of left ventricular ejection fraction using an ultrasonic stethoscope in critically ill patients.Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitisPseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomesProstatic abscesses and severe sepsis due to methicillin-susceptible Staphylococcus aureus producing Panton-Valentine leukocidinCardiac tamponade related to a coronary injury by a pericardial calcification: an unusual complicationHemodynamic monitoring using a single-use indwelling transesophageal echocardiography probe in an unstable patient after open-heart surgeryA randomized, placebo-controlled trial of preemptive antifungal therapy for the prevention of invasive candidiasis following gastrointestinal surgery for intra-abdominal infections.What strategy should France implement for H2020?Extracorporeal albumin dialysis in three cases of acute calcium channel blocker poisoning with life-threatening refractory cardiogenic shock.DNA microarray analysis and functional profile of pituitary transcriptome under core-clock protein BMAL1 control.Strengths and limitations of industry vs. academic randomized controlled trials.Severe Rhabdomyolysis Associated with Staphylococcus aureus Acute Endocarditis Requiring Surgery.The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.Adherence to online monitoring of patient-reported outcomes by patients with chronic inflammatory diseases: a feasibility study.Molecular quantification of bacteria from respiratory samples in patients with suspected ventilator-associated pneumonia.Prognostic impact of left ventricular diastolic function in patients with septic shockBeing Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit.The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia.Alternatives to antibiotics.Rapid quantification of Staphylococcus aureus from endotracheal aspirates of ventilated patients: a proof-of-concept study.Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-α fragment antibody AZD9773 in adult patients with severe sepsis and/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*.Global prospective epidemiologic and surveillance study of ventilator-associated pneumonia due to Pseudomonas aeruginosa.Facial purpura associated with Capnocytophaga canimorsus septicaemia; role of sunlight?Severe human bone infection due to methicillin-resistant Staphylococcus aureus carrying the novel mecC variant.Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit.Evidence in the eye of the beholder: about probiotics and VAP prevention.Hemodynamic assessment of ventilated ICU patients with cardiorespiratory failure using a miniaturized multiplane transesophageal echocardiography probe.Assessment of panobacumab as adjunctive immunotherapy for the treatment of nosocomial Pseudomonas aeruginosa pneumonia.Two-step bacterial broad-range polymerase chain reaction analysis of heart valve tissue improves bacteriological diagnosis of infective endocarditis.Value of integron detection for predicting antibiotic resistance in patients with Gram-negative septicaemia.Early bacterial genome detection in body fluids from patients with severe sepsis: a pilot study.Response to Letter Regarding Article, “Endovascular Versus External Targeted Temperature Management for Patients With Out-of-Hospital Cardiac Arrest: A Randomized, Controlled Study”Circulating Immature Granulocytes With T-Cell Killing Functions Predict Sepsis Deterioration*Immature Granulocytes: A Risk Factor of Infection after Cardiac SurgeryNew molecular semi-quantification tool provides reliable microbiological evidence for pulmonary infectionSafety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trialPromoting the Place of the Allied Health Professions in Clinical ResearchSafety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa
P50
Q26749328-08353924-B015-4739-B114-BF986509F760Q28069198-4707EFF8-0802-4C08-A110-A04902A638B1Q30465719-4E1A29F3-8498-4F61-BB6A-22C4287B77F8Q30567342-95077699-B9C1-4815-8638-8D210B9799C1Q33754176-332D73EC-3ADB-4578-B30C-62206C5FF250Q34143887-66994D05-BAC4-44F8-B116-3129CB634BB3Q34245369-3A846636-A415-4FF3-9EFF-192FBB4ACA35Q35745436-F7BBD27A-A663-41B4-A297-7702790EA1C1Q36276211-96B7F5B6-A75A-40B7-9966-492336FA2D9EQ38369627-BB0F35D8-86EB-48A3-BD61-0C05E286C060Q38462454-95A5B9F8-9F66-4167-A8CC-7C3245F01DAFQ38498427-AC808EE9-C599-4B5F-9CC9-BEE865EA2D61Q38548763-7B77CECB-258A-4F65-A121-1BBF52DBC70BQ38565276-290212D6-8480-4DC3-B994-3DFE9635A1F4Q38633668-AF33C11F-0134-4A6E-B379-A226BA4335F3Q39007658-0D87648B-A076-4F84-8C45-3C8874AD6F07Q39610228-5E36E393-A8DF-485E-98EA-66B18589571EQ40426483-B290547D-4655-4993-AC22-8450BDBAE315Q40477274-D482ECB0-0D6D-41E1-BA67-BF9A51F8F5F7Q40591899-7E099ECC-C544-4F19-A4A1-412B3AB39A1DQ40733237-5FE30176-A5B8-44E8-B09B-F332310CCAF9Q41080655-1942195A-7459-443A-81F4-6AB6221F78E2Q42236968-490B6C40-DB50-49B1-9D16-64492C0F1F58Q44540920-DD153D75-D013-4AF1-88AA-C10EE9BFFC37Q46405407-544A7131-44C7-441F-8434-C0479836691FQ46831707-DA6F8C4A-78B9-4E9E-8662-63482E5A83ADQ46925063-1330DFA6-BFA8-4AA7-B576-7A7A92BD20E8Q49057871-466A3CC5-7BE7-411D-B70E-5BDF459220D2Q51605828-93CB2813-7DA7-4059-B3D1-825CA580C6A7Q51732617-6DFDD27C-77D5-44AD-9692-DE34B1129202Q51838244-26B2D244-94D6-42DA-9DB3-7E378C07F8EFQ54194509-1DD40133-D52C-41BE-8333-538E5B0553C6Q54330448-497F5EBC-964A-45C3-912A-30965EBFD882Q57016604-766A32A5-8A14-49FB-95C6-EFF7BAA45D17Q57219590-A6903E12-D70C-4CA9-A0E2-AA0E43797D4BQ57456716-93B97266-CB29-4105-B7E5-D43D4D798DE9Q57803259-7F6D6235-4146-4A6E-A5A7-E4DE1F4695E3Q57806609-D0B3788D-ADCD-4346-982F-69F28BE186BEQ58158540-1FFBAD06-6E66-4D3F-9E68-F6E8A7657C8CQ59387600-A89EB950-E68A-412D-A8D2-EF042F9CCC5C
P50
description
researcher ORCID ID = 0000-0002-2531-1652
@en
wetenschapper
@nl
name
Bruno François
@ast
Bruno François
@en
Bruno François
@nl
type
label
Bruno François
@ast
Bruno François
@en
Bruno François
@nl
prefLabel
Bruno François
@ast
Bruno François
@en
Bruno François
@nl
P106
P21
P31
P496
0000-0002-2531-1652